LLY |
Eli Lilly and Company |
728.85B |
17.51% |
|
|
|
|
|
767.76 |
1.35% |
37.07% |
38.72% |
---|
BMY |
Bristol-Myers Squibb Company |
116.28B |
6.88% |
|
|
|
|
|
57.33 |
1.83% |
28.90% |
41.38% |
---|
USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
6.83% |
|
|
|
|
|
|
|
|
|
---|
NVS |
Novartis AG |
189.99B |
6.39% |
|
|
|
|
|
97.11 |
0.35% |
20.41% |
47.19% |
---|
AMGN |
Amgen Inc. |
141.58B |
6.04% |
|
|
|
|
|
263.38 |
0.84% |
25.97% |
20.88% |
---|
AZN |
AstraZeneca PLC |
202.63B |
5.53% |
|
|
|
|
|
65.35 |
1.41% |
24.74% |
48.78% |
---|
JNJ |
Johnson & Johnson |
347.83B |
5.05% |
|
|
|
|
|
144.47 |
0.62% |
19.93% |
50.22% |
---|
ALKS |
Alkermes plc |
4.81B |
4.75% |
|
|
|
|
|
29.71 |
-0.87% |
46.26% |
66.15% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
31.66B |
4.73% |
|
|
|
|
|
245.44 |
2.75% |
37.31% |
31.83% |
---|
MRK |
Merck & Co., Inc. |
248.03B |
4.60% |
|
|
|
|
|
98.05 |
-1.48% |
25.78% |
55.19% |
---|
PFE |
Pfizer Inc. |
149.38B |
4.60% |
|
|
|
|
|
26.36 |
2.29% |
26.92% |
45.78% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
75.85B |
3.51% |
|
|
|
|
|
701.85 |
-0.90% |
34.78% |
72.04% |
---|
BIIB |
Biogen Inc. |
21.34B |
3.16% |
|
|
|
|
|
146.47 |
-0.62% |
33.95% |
70.80% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
5.63B |
3.06% |
|
|
|
|
|
35.63 |
0.11% |
47.85% |
72.37% |
---|
CRSP |
CRISPR Therapeutics AG |
3.48B |
2.93% |
|
|
|
|
|
40.72 |
0.83% |
58.99% |
29.19% |
---|
GSK |
GSK plc |
68.55B |
2.59% |
|
|
|
|
|
33.60 |
0.51% |
24.77% |
66.75% |
---|
BEAM |
Beam Therapeutics Inc. |
2.40B |
1.77% |
|
|
|
|
|
29.01 |
8.04% |
71.59% |
58.49% |
---|
BCYC |
Bicycle Therapeutics plc |
1.01B |
1.49% |
|
|
|
|
|
14.68 |
-2.13% |
104.90% |
46.64% |
---|
NTLA |
Intellia Therapeutics, Inc. |
1.24B |
1.20% |
|
|
|
|
|
12.18 |
0.83% |
101.81% |
102.14% |
---|
REPL |
Replimune Group, Inc. |
941.00M |
1.19% |
|
|
|
|
|
12.49 |
4.00% |
219.38% |
10.27% |
---|
HLN |
Haleon plc |
43.86B |
0.94% |
|
|
|
|
|
9.69 |
-0.10% |
44.89% |
37.62% |
---|
VNDA |
Vanda Pharmaceuticals Inc. |
278.71M |
0.83% |
|
|
|
|
|
4.78 |
3.24% |
86.75% |
32.00% |
---|
GALT |
Galectin Therapeutics Inc. |
64.80M |
0.74% |
|
|
|
|
|
1.0400 |
-48.00% |
544.46% |
99.23% |
---|
LTRN |
Lantern Pharma Inc. |
33.92M |
0.64% |
|
|
|
|
|
3.15 |
-2.02% |
324.46% |
39.65% |
---|
SDZNY |
Sandoz Group AG |
|
0.55% |
|
|
|
|
|
|
|
|
|
---|
GEHC |
GE HealthCare Technologies Inc. |
36.05B |
0.51% |
|
|
|
|
|
78.91 |
1.91% |
26.24% |
32.16% |
---|
Cash&Other |
Cash & Other |
|
0.46% |
|
|
|
|
|
|
|
|
|
---|
TSVT |
2seventy bio, Inc. |
161.99M |
0.35% |
|
|
|
|
|
3.14 |
7.53% |
175.76% |
30.01% |
---|
VTRS |
Viatris Inc. |
14.94B |
0.30% |
|
|
|
|
|
12.52 |
3.22% |
30.30% |
30.97% |
---|
EDIT |
Editas Medicine, Inc. |
108.14M |
0.29% |
|
|
|
|
|
1.3100 |
-2.24% |
242.80% |
79.35% |
---|
ALLO |
Allogene Therapeutics, Inc. |
392.09M |
0.24% |
|
|
|
|
|
1.8700 |
1.63% |
225.38% |
54.34% |
---|
PACB |
Pacific Biosciences of California, Inc. |
539.51M |
0.15% |
|
|
|
|
|
1.9700 |
2.07% |
138.53% |
38.25% |
---|
BLUE |
bluebird bio, Inc. |
82.64M |
0.12% |
|
|
|
|
|
8.50 |
-7.91% |
157.09% |
49.78% |
---|
MURA |
Mural Oncology plc |
54.25M |
0.05% |
|
|
|
|
|
3.18 |
1.27% |
282.63% |
18.42% |
---|
SLRX |
Salarius Pharmaceuticals, Inc. |
2.23M |
0.04% |
|
|
|
|
|
1.5500 |
9.93% |
N/A |
N/A |
---|
2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
---|